Detalhe da pesquisa
1.
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Nature
; 628(8007): 416-423, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38538786
2.
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Blood
; 141(25): 3031-3038, 2023 06 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37084383
3.
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Blood
; 139(10): 1452-1468, 2022 03 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34724567
4.
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial.
Blood
; 137(3): 420-428, 2021 01 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33475736
5.
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Blood
; 138(3): 273-282, 2021 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34292325
6.
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Blood
; 137(23): 3291-3305, 2021 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33657221
7.
Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel.
Br J Haematol
; 199(5): 720-727, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36111395
8.
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation.
Br J Haematol
; 194(1): 145-157, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34124796
9.
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study.
Biol Blood Marrow Transplant
; 26(9): 1679-1688, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32592857
10.
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 26(12): 2306-2310, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32961372
11.
Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(11): 2075-2081, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32818556
12.
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia.
Biol Blood Marrow Transplant
; 26(3): 502-508, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31730920
13.
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Biol Blood Marrow Transplant
; 26(10): 1930-1936, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32649981
14.
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT.
Haematologica
; 105(1): 47-58, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31537691
15.
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 25(6): 1128-1135, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30599208
16.
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): 2431-2437, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31394272
17.
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1859-1868, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31132455
18.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood
; 129(10): 1389-1393, 2017 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28049637
19.
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(2): 343-352, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29055682
20.
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016.
Biol Blood Marrow Transplant
; 24(5): 895-908, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29339270